Inovio Pharmaceuticals, Inc.
INO
$2.04
$0.094.62%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 27.04% | 35.36% | 22.48% | 25.83% | 9.28% |
| Total Depreciation and Amortization | -10.49% | -2.13% | 342.81% | -25.84% | -27.53% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 31.62% | -274.80% | -149.27% | -101.65% | -67.08% |
| Change in Net Operating Assets | -94.69% | -460.79% | 65.37% | 61.26% | 179.17% |
| Cash from Operations | 26.23% | 6.56% | 25.16% | 5.73% | 12.70% |
| Capital Expenditure | 93.17% | -66.85% | -- | -- | -1,792.47% |
| Sale of Property, Plant, and Equipment | -- | -- | -60.01% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -49.00% | -99.98% | 74.72% | 356.25% | -80.68% |
| Cash from Investing | -47.00% | -100.11% | 73.71% | 356.25% | -81.51% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -78.91% | 611.61% | -5.82% | 487.52% |
| Repurchase of Common Stock | 85.51% | 57.41% | -- | 34.02% | -643.34% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.11% | 109.05% | 1,485.45% | -5.44% | 1,045.85% |
| Foreign Exchange rate Adjustments | -- | -- | -100.00% | 100.00% | 100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -205.23% | -589.47% | 1,081.95% | 62.53% | -39.57% |